{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:44:01Z","timestamp":1793317441881,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T00:00:00Z","timestamp":1645660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257544"],"award-info":[{"award-number":["R01CA257544"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257544"],"award-info":[{"award-number":["R01CA257544"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA217992"],"award-info":[{"award-number":["R01CA217992"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R21CA249138"],"award-info":[{"award-number":["R21CA249138"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"Torsten Haferlach Leukamiediagnostik Stiftung"},{"DOI":"10.13039\/100000092","name":"U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM013067"],"award-info":[{"award-number":["R01LM013067"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although recent work has described the microbiome in solid tumors, microbial content in hematological malignancies is not well-characterized. Here we analyze existing deep DNA sequence data from the blood and bone marrow of 1870 patients with myeloid malignancies, along with healthy controls, for bacterial, fungal, and viral content. After strict quality filtering, we find evidence for dysbiosis in disease cases, and distinct microbial signatures among disease subtypes. We also find that microbial content is associated with host gene mutations and with myeloblast cell percentages. In patients with low-risk myelodysplastic syndrome, we provide evidence that Epstein-Barr virus status refines risk stratification into more precise categories than the current standard. Motivated by these observations, we construct machine-learning classifiers that can discriminate among disease subtypes based solely on bacterial content. Our study highlights the association between the circulating microbiome and patient outcome, and its relationship with disease subtype.<\/jats:p>","DOI":"10.1038\/s41467-022-28678-x","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T06:02:48Z","timestamp":1645682568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes"],"prefix":"10.1038","volume":"13","author":[{"given":"Jakob","family":"Woerner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4662-8664","authenticated-orcid":false,"given":"Yidi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2432-8898","authenticated-orcid":false,"given":"Stephan","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6829-5544","authenticated-orcid":false,"given":"Carmelo","family":"Gurnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mar\u00eda Hern\u00e1ndez","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6077-388X","authenticated-orcid":false,"given":"Vedant","family":"Thorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7660-5255","authenticated-orcid":false,"given":"Babal K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Koyuturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6837-4346","authenticated-orcid":false,"given":"Jaroslaw P.","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-4777","authenticated-orcid":false,"given":"Thomas","family":"LaFramboise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,24]]},"reference":[{"key":"28678_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber, D. A. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127, 2391\u20132405 (2016).","journal-title":"Blood"},{"key":"28678_CR2","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1016\/j.ejca.2012.05.024","volume":"48","author":"O Visser","year":"2012","unstructured":"Visser, O. et al. Incidence, survival and prevalence of myeloid malignancies in Europe. Eur. J. Cancer 48, 3257\u20133266 (2012).","journal-title":"Eur. J. Cancer"},{"key":"28678_CR3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1158\/1055-9965.EPI-11-1087","volume":"21","author":"BM Craig","year":"2012","unstructured":"Craig, B. M., Rollison, D. E., List, A. F. & Cogle, C. R. Underreporting of myeloid malignancies by United States cancer registries. Cancer Epidemiol. Biomark. Prev. 21, 474\u2013481 (2012).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"28678_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","volume":"36","author":"RM Shallis","year":"2019","unstructured":"Shallis, R. M., Wang, R., Davidoff, A., Ma, X. & Zeidan, A. M. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 36, 70\u201387 (2019).","journal-title":"Blood Rev."},{"key":"28678_CR5","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","volume":"13","author":"C de Martel","year":"2012","unstructured":"de Martel, C. et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. 13, 607\u2013615 (2012).","journal-title":"Lancet Oncol."},{"key":"28678_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/jcp.2007.052456","volume":"60","author":"E Matutes","year":"2007","unstructured":"Matutes, E. Adult T-cell leukaemia\/lymphoma. J. Clin. Pathol. 60, 1373\u20131377 (2007).","journal-title":"J. Clin. Pathol."},{"key":"28678_CR7","first-page":"1397","volume":"60","author":"G Brady","year":"2007","unstructured":"Brady, G., MacArthur, G. J. & Farrell, P. J. Epstein-Barr virus and Burkitt lymphoma. J. Clin. Pathol. 60, 1397\u20131402 (2007).","journal-title":"J. Clin. Pathol."},{"key":"28678_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1056\/NEJMoa1900623","volume":"382","author":"JU Peled","year":"2020","unstructured":"Peled, J. U. et al. Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 382, 822\u2013834 (2020).","journal-title":"N. Engl. J. Med."},{"key":"28678_CR9","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","volume":"124","author":"Y Taur","year":"2014","unstructured":"Taur, Y. et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 124, 1174\u20131182 (2014).","journal-title":"Blood"},{"key":"28678_CR10","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.116.307709","volume":"118","author":"MM Santisteban","year":"2016","unstructured":"Santisteban, M. M., Kim, S., Pepine, C. J. & Raizada, M. K. Brain\u2013gut\u2013bone marrow axis: implications for hypertension and related therapeutics. Circ. Res 118, 1327\u20131336 (2016).","journal-title":"Circ. Res"},{"key":"28678_CR11","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.bbmt.2018.02.009","volume":"24","author":"TM Andermann","year":"2018","unstructured":"Andermann, T. M. et al. The microbiome and hematopoietic cell transplantation: past, present, and future. Biol. Blood Marrow Transpl. 24, 1322\u20131340 (2018).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"28678_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","volume":"178","author":"E Riquelme","year":"2019","unstructured":"Riquelme, E. et al. Tumor microbiome diversity and composition influence pancreatic cancer outcomes. Cell 178, 795\u2013806 e712 (2019).","journal-title":"Cell"},{"key":"28678_CR13","doi-asserted-by":"publisher","first-page":"97273","DOI":"10.18632\/oncotarget.21921","volume":"8","author":"PK Mukherjee","year":"2017","unstructured":"Mukherjee, P. K. et al. Bacteriome and mycobiome associations in oral tongue cancer. Oncotarget 8, 97273\u201397289 (2017).","journal-title":"Oncotarget"},{"key":"28678_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11894-018-0642-9","volume":"20","author":"B Corning","year":"2018","unstructured":"Corning, B., Copland, A. P. & Frye, J. W. The esophageal microbiome in health and disease. Curr. Gastroenterol. Rep. 20, 39 (2018).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"28678_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman, D. et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science 368, 973\u2013980 (2020).","journal-title":"Science"},{"key":"28678_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2095-1","volume":"579","author":"GD Poore","year":"2020","unstructured":"Poore, G. D. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 579, 567\u2013574 (2020).","journal-title":"Nature"},{"key":"28678_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3389\/fcimb.2019.00148","volume":"9","author":"DJ Castillo","year":"2019","unstructured":"Castillo, D. J., Rifkin, R. F., Cowan, D. A. & Potgieter, M. The healthy human blood microbiome: fact or fiction? Front. Cell. Infect. Microbiol. 9, 148 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"28678_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jim.2014.12.015","volume":"421","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Methods to determine intestinal permeability and bacterial translocation during liver disease. J. immunol. Methods 421, 44\u201353 (2015).","journal-title":"J. immunol. Methods"},{"key":"28678_CR19","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1093\/bioinformatics\/bty501","volume":"34","author":"MA Walker","year":"2018","unstructured":"Walker, M. A. et al. GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts. Bioinformatics. 34, 4287\u20134289 (2018).","journal-title":"Bioinformatics"},{"key":"28678_CR20","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1101\/gr.245373.118","volume":"29","author":"FP Breitwieser","year":"2019","unstructured":"Breitwieser, F. P., Pertea, M., Zimin, A. V. & Salzberg, S. L. Human contamination in bacterial genomes has created thousands of spurious proteins. Genome Res. 29, 954\u2013960 (2019).","journal-title":"Genome Res."},{"key":"28678_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ijid.2017.11.028","volume":"67","author":"S Fan","year":"2018","unstructured":"Fan, S. et al. Next-generation sequencing of the cerebrospinal fluid in the diagnosis of neurobrucellosis. Int. J. Infect. Dis. 67, 20\u201324 (2018).","journal-title":"Int. J. Infect. Dis."},{"key":"28678_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-014-0087-z","volume":"12","author":"SJ Salter","year":"2014","unstructured":"Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 (2014).","journal-title":"BMC Biol."},{"key":"28678_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/lam.13091","volume":"68","author":"LF Stinson","year":"2019","unstructured":"Stinson, L. F., Keelan, J. A. & Payne, M. S. Identification and removal of contaminating microbial DNA from PCR reagents: impact on low-biomass microbiome analyses. Lett. Appl. Microbiol. 68, 2\u20138 (2019).","journal-title":"Lett. Appl. Microbiol."},{"key":"28678_CR24","first-page":"1","volume":"331","author":"H Okamoto","year":"2009","unstructured":"Okamoto, H. History of discoveries and pathogenicity of TT viruses. Curr. Top. Microbiol. Immunol. 331, 1\u201320 (2009).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"28678_CR25","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1182\/blood.2021011677","volume":"138","author":"A Astolfi","year":"2021","unstructured":"Astolfi, A. et al. Torque teno mini virus as a cause of childhood acute promyelocytic leukemia lacking PML\/RARA fusion. Blood 138, 1773\u20131777 (2021).","journal-title":"Blood"},{"key":"28678_CR26","doi-asserted-by":"publisher","first-page":"8058","DOI":"10.1073\/pnas.1502741112","volume":"112","author":"A Gravel","year":"2015","unstructured":"Gravel, A. et al. Inherited chromosomally integrated human herpesvirus 6 as a predisposing risk factor for the development of angina pectoris. Proc. Natl Acad. Sci. USA 112, 8058\u20138063 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"28678_CR27","doi-asserted-by":"publisher","first-page":"1627824","DOI":"10.1155\/2020\/1627824","volume":"2020","author":"J de Melo Silva","year":"2020","unstructured":"de Melo Silva, J., Pinheiro-Silva, R., Dhyani, A. & Pontes, G. S. Cytomegalovirus and Epstein-Barr infections: prevalence and impact on patients with hematological diseases. BioMed. Res. Int. 2020, 1627824 (2020).","journal-title":"BioMed. Res. Int."},{"key":"28678_CR28","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg, P. L. et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 120, 2454\u20132465 (2012).","journal-title":"Blood"},{"key":"28678_CR29","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.7150\/thno.29622","volume":"9","author":"M Xu","year":"2019","unstructured":"Xu, M. et al. Genome-wide profiling of Epstein-Barr virus integration by targeted sequencing in Epstein-Barr virus associated malignancies. Theranostics 9, 1115\u20131124 (2019).","journal-title":"Theranostics"},{"key":"28678_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/hepr.13580","volume":"51","author":"M Li","year":"2021","unstructured":"Li, M. et al. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinoma. Hepatol. Res. 51, 102\u2013115 (2021).","journal-title":"Hepatol. Res."},{"key":"28678_CR31","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/00365540410017563","volume":"36","author":"DP Kontoyiannis","year":"2004","unstructured":"Kontoyiannis, D. P. et al. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand. J. Infect. Dis. 36, 564\u2013569 (2004).","journal-title":"Scand. J. Infect. Dis."},{"key":"28678_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1086\/421944","volume":"39","author":"Z Odabasi","year":"2004","unstructured":"Odabasi, Z. et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39, 199\u2013205 (2004).","journal-title":"Clin. Infect. Dis."},{"key":"28678_CR33","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1600-0609.2010.01410.x","volume":"84","author":"K Suzuki","year":"2010","unstructured":"Suzuki, K. et al. Fatal Trichosporon fungemia in patients with hematologic malignancies. Eur. J. Haematol. 84, 441\u2013447 (2010).","journal-title":"Eur. J. Haematol."},{"key":"28678_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220\u2013230 (2012).","journal-title":"Nature"},{"key":"28678_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","volume":"67","author":"RM Ferreira","year":"2018","unstructured":"Ferreira, R. M. et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut 67, 226\u2013236 (2018).","journal-title":"Gut"},{"key":"28678_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1114-x","volume":"17","author":"S Canisius","year":"2016","unstructured":"Canisius, S., Martens, J. W. & Wessels, L. F. A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence. Genome Biol. 17, 261 (2016).","journal-title":"Genome Biol."},{"key":"28678_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/microorganisms7010014","volume":"7","author":"E Rinninella","year":"2019","unstructured":"Rinninella, E. et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7, 14 (2019).","journal-title":"Microorganisms"},{"key":"28678_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ygeno.2012.04.003","volume":"99","author":"X Chen","year":"2012","unstructured":"Chen, X. & Ishwaran, H. Random forests for genomic data analysis. Genomics 99, 323\u2013329 (2012).","journal-title":"Genomics"},{"key":"28678_CR39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1023\/A:1010920819831","volume":"45","author":"DJ Hand","year":"2001","unstructured":"Hand, D. J. & Till, R. J. A simple generalisation of the area under the ROC curve for multiple class classification problems. Mach. Lean. 45, 171\u2013186 (2001).","journal-title":"Mach. Lean."},{"key":"28678_CR40","doi-asserted-by":"publisher","first-page":"115118","DOI":"10.1016\/j.diagmicrobio.2020.115118","volume":"98","author":"C Schaub","year":"2020","unstructured":"Schaub, C. et al. Relevance of Dermabacter hominis isolated from clinical samples, 2012\u20132016: a retrospective case series. Diagn. Microbiol. Infect. Dis. 98, 115118 (2020).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"28678_CR41","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1128\/JCM.01245-11","volume":"50","author":"O Blennow","year":"2012","unstructured":"Blennow, O., Westling, K., Froding, I. & Ozenci, V. Pneumonia and bacteremia due to Kytococcus schroeteri. J. Clin. Microbiol. 50, 522\u2013524 (2012).","journal-title":"J. Clin. Microbiol."},{"key":"28678_CR42","first-page":"217307","volume":"2015","author":"A Amaraneni","year":"2015","unstructured":"Amaraneni, A., Malik, D., Jasra, S., Chandana, S. R. & Garg, D. Kytococcus schroeteri Bacteremia in a patient with hairy cell leukemia: a case report and review of the literature. Case Rep. Infect. Dis. 2015, 217307 (2015).","journal-title":"Case Rep. Infect. Dis."},{"key":"28678_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41586-018-0125-z","volume":"557","author":"M Meisel","year":"2018","unstructured":"Meisel, M. et al. Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557, 580\u2013584 (2018).","journal-title":"Nature"},{"key":"28678_CR44","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research, N.","year":"2013","unstructured":"Cancer Genome Atlas Research, N. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"28678_CR45","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/leu.2013.336","volume":"28","author":"T Haferlach","year":"2014","unstructured":"Haferlach, T. et al. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28, 241\u2013247 (2014).","journal-title":"Leukemia"},{"key":"28678_CR46","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616\u20133627 (2013). quiz 3699.","journal-title":"Blood"},{"key":"28678_CR47","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.3389\/fmicb.2018.03266","volume":"9","author":"E Whittle","year":"2018","unstructured":"Whittle, E., Leonard, M. O., Harrison, R., Gant, T. W. & Tonge, D. P. Multi-method characterization of the human circulating microbiome. Front. Microbiol. 9, 3266 (2018).","journal-title":"Front. Microbiol."},{"key":"28678_CR48","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/trf.13477","volume":"56","author":"S Paisse","year":"2016","unstructured":"Paisse, S. et al. Comprehensive description of blood microbiome from healthy donors assessed by 16S targeted metagenomic sequencing. Transfusion 56, 1138\u20131147 (2016).","journal-title":"Transfusion"},{"key":"28678_CR49","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0609.1998.tb01710.x","volume":"61","author":"GM Sundstrom","year":"1998","unstructured":"Sundstrom, G. M., Wahlin, A., Nordin-Andersson, I. & Suhr, O. B. Intestinal permeability in patients with acute myeloid leukemia. Eur. J. Haematol. 61, 250\u2013254 (1998).","journal-title":"Eur. J. Haematol."},{"key":"28678_CR50","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ccell.2018.08.016","volume":"34","author":"H Ye","year":"2018","unstructured":"Ye, H. et al. Subversion of systemic glucose metabolism as a mechanism to support the growth of leukemia cells. Cancer Cell 34, 659\u2013673 e656 (2018).","journal-title":"Cancer Cell"},{"key":"28678_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1182\/blood.V9.6.557.557","volume":"9","author":"L Gross","year":"1954","unstructured":"Gross, L. Is leukemia caused by a transmissible virus? A working hypothesis. Blood 9, 557\u2013573 (1954).","journal-title":"Blood"},{"key":"28678_CR52","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli, A. H. et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118, 1402\u20131412 (2011).","journal-title":"Blood"},{"key":"28678_CR53","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/jmv.24797","volume":"89","author":"H Guan","year":"2017","unstructured":"Guan, H., Miao, H., Ma, N., Lu, W. & Luo, B. Correlations between Epstein-Barr virus and acute leukemia. J. Med. Virol. 89, 1453\u20131460 (2017).","journal-title":"J. Med. Virol."},{"key":"28678_CR54","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/leu.2017.181","volume":"31","author":"R Bejar","year":"2017","unstructured":"Bejar, R. CHIP, ICUS, CCUS and other four-letter words. Leukemia 31, 1869\u20131871 (2017).","journal-title":"Leukemia"},{"key":"28678_CR55","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","volume":"469","author":"R Ranjan","year":"2016","unstructured":"Ranjan, R., Rani, A., Metwally, A., McGee, H. S. & Perkins, D. L. Analysis of the microbiome: advantages of whole genome shotgun versus 16S amplicon sequencing. Biochem. Biophys. Res. Commun. 469, 967\u2013977 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"28678_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2018.11.003","volume":"27","author":"R Eisenhofer","year":"2019","unstructured":"Eisenhofer, R. et al. Contamination in low microbial biomass microbiome studies: issues and recommendations. Trends Microbiol. 27, 105\u2013117 (2019).","journal-title":"Trends Microbiol."},{"key":"28678_CR57","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.abf3363","volume":"371","author":"D Davar","year":"2021","unstructured":"Davar, D. et al. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients. Science 371, 595\u2013602 (2021).","journal-title":"Science"},{"key":"28678_CR58","unstructured":"McGowan-Jordan, J., Simons, A. & Schmid, M. ISCN: An International System for Human Cytogenomic Nomenclature (International Standing Committee on Human Cytogenomic Nomenclature, 2016)."},{"key":"28678_CR59","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"28678_CR60","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"28678_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13056-x","volume":"10","author":"D Kobak","year":"2019","unstructured":"Kobak, D. & Berens, P. The art of using t-SNE for single-cell transcriptomics. Nat. Commun. 10, 5416 (2019).","journal-title":"Nat. Commun."},{"key":"28678_CR62","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41592-018-0308-4","volume":"16","author":"GC Linderman","year":"2019","unstructured":"Linderman, G. C., Rachh, M., Hoskins, J. G., Steinerberger, S. & Kluger, Y. Fast interpolation-based t-SNE for improved visualization of single-cell RNA-seq data. Nat. methods 16, 243\u2013245 (2019).","journal-title":"Nat. methods"},{"key":"28678_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-7-252","volume":"7","author":"ML Lay","year":"2010","unstructured":"Lay, M. L. et al. Measurement of Epstein-Barr virus DNA load using a novel quantification standard containing two EBV DNA targets and SYBR Green I dye. Virol. J. 7, 252 (2010).","journal-title":"Virol. J."},{"key":"28678_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1749-6632.2000.tb06597.x","volume":"906","author":"YM Lo","year":"2000","unstructured":"Lo, Y. M. et al. Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann. N. Y. Acad. Sci. 906, 99\u2013101 (2000).","journal-title":"Ann. N. Y. Acad. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28678-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28678-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T16:09:56Z","timestamp":1674835796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28678-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,24]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28678"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28678-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-380836\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,24]]},"assertion":[{"value":"6 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1038"}}